8/26/2024UCB Sells Chinese Neurology and Allergy Business for $680M

8/26/2024CDE Solicits Public Comments on the Technical Guidelines for Pharmaceu...

8/26/2024China Issues the Notice on Facilitating the BMI for Urban and Rural Re...

8/26/2024China Escalates Crackdown on Medical Insurance Frauds

8/26/2024Over 70% of Village Clinics Now Covered by the BMI System

8/23/2024Recent Executive Moves

8/22/2024Everest Medicines Announces Initiation of Clinical Trial for Personali...

8/22/2024China Further Opens Telecom, Education, and Healthcare Sectors to Fore...

8/22/2024What Drives China's Healthcare Expenditure? A Theoretical and Empirica...

8/20/2024Taking Stock of U.S.-China Biotechnology Competition (Asia Society)

8/20/2024Merck Adjusts ADC Partnership with Kelun-Biotech, Takes Up One Option ...

8/20/2024Adcendo Enters $1B Biobuck Deal for Multitude's Anti-TF ADC

8/20/2024U.S. Lawmakers Call on the FDA to Investigate Clinical Trials Conducte...

8/20/2024AstraZeneca Gains Chinese Approval of New Asthma Drug

8/19/2024Astellas Secures Chinese Approval of Nectin-4 ADC Drug

8/19/2024NMPA Restores Import, Sales and Use of UCB's Keppra

8/19/2024Germany Warns of Potential Drug Shortages Due to China's Espionage Law

8/19/2024FDA Lifts Partial Hold on BioNTech-MediLink ADC Study

8/16/2024Huadong Secures Asia Rights to Two South Korean Autoimmune Disease Dru...

8/16/2024Recent Official and Executive Moves

8/15/2024Akeso's sNDA for Ivonescimab (PD-1/VEGF) Granted Priority Review in Ch...

8/15/2024SAMR Releases Draft Pharma Anti-monopoly Guidelines

8/15/2024China Introduces Guidelines to Encourage Development of 'Digital, Smar...

8/15/2024Patent Term Compensation: New Policy Interpretation And Operation Guid...

8/14/2024China Biopharma Tracker – July 2024 (PharmaDJ)

8/14/2024Apollomics Announces Positive Preliminary Data of Vebreltinib

8/13/2024OcuMension Acquires China Rights to Alcon Eye Drops with 16.7% Equity ...

8/13/2024MNC Pharma Companies in China Return to Growth after Years of VBP Turb...

8/13/2024Junshi's sNDA for Toripalimab as First-Line Treatment of Unresectable/...

8/9/2024Sable Thera Announces Worldwide Licensing Deal with Columbia Univers...

Page:25/359 Total number of articles:10756: [First][<<] [23] [24] [25] [26] [27] [>>] [End]